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Abstract
Background: The World Health Organization recommends cervical cancer screening and vaccination programmes
as measures to combat cervical cancer. The uptake of these measures remains low in Uganda, most especially in
rural areas. An understanding of the factors that influence women’s decision to attend screening, and willingness to have
their daughters vaccinated against cervical cancer is essential for any attempts to increase uptake of these services. This
study assessed the factors associated with intention to screen for cervical cancer among women in eastern Uganda, and
willingness to have their daughters vaccinated against the disease.
Methods: This cross sectional study involved 900 females aged 25 to 49 years in Bugiri and Mayuge districts in eastern
Uganda. Data were collected using a pretested semi-structured questionnaire, entered in Epidata version 3.02 and
analysed in STATA version 12.0. Unadjusted and adjusted prevalence ratios (PR) were computed using a generalized
linear model with Poisson family, and a log link with robust standard errors.
Results: Majority 819 (91.0%) of respondents stated that they intended to go for cervical cancer screening in the
subsequent six months. Among them, 603 (73.6%) wanted to know their status, 256 (31.3%) thought it was
important, 202 (24.7%) wanted to reduce their chances of getting the disease, and 20 (2.4%) had been told
to do so by a health worker. Majority 813 (90.4%) of respondents were willing to vaccinate their daughters
against cervical cancer. Higher income (adjusted PR = 1.11, 95% CI: 1.03–1.20), cervical cancer screening status
(adjusted PR = 0.81, 95% CI: 0.67–0.99) and knowledge of at least one test for cervical cancer (adjusted PR = 0.
92, 95% CI: 0.85–0.98) were significantly associated with intention to screen for cervical cancer. No socio-demographic
characteristic was associated with willingness to vaccinate daughters among women.
Conclusion: There is a very high intention to screen and willingness to vaccinate daughters against cervical cancer
among women in eastern Uganda. To take advantage of this, there is need to avail opportunities for women to access
cervical cancer screening and vaccinations particularly among rural communities.
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Background
Cervical cancer remains a major cause of morbidity and
mortality among women in resource constrained settings
due to low access to cancer screening and vaccination
[1, 2]. Indeed, coverage of cancer screening services is
lowest in low and middle income countries [3]. These
countries have only a few trained and skilled health
workers to carry out screening, and lack healthcare re-
sources to sustain such programmes [4]. Consequently,
women with cervical cancer are not identified until they
are at an advanced stage of disease, resulting in high
morbidity and mortality [4]. On the other hand, many
developing countries are still in the initial stages of roll-
ing out cervical cancer vaccination among their popula-
tions. For example, in Uganda, cervical cancer
vaccinations among girls aged between 9 to 13 years in
schools and the community were piloted in 2008 and a
national strategic plan launched in 2010 [5, 6]. Other
sub-Saharan African countries such as Ghana and Kenya
have also rolled out cervical cancer vaccinations among
their population [7, 8].
Cervical cancer is potentially preventable, and effective
screening programmes can lead to a significant reduc-
tion in the morbidity and mortality associated with this
cancer [2, 9] especially if detected in early stages [10].
The World Health Organization (WHO) recommends
screening and vaccination programmes globally [11].
However, only a small percentage (5–27%) of women in
sub-Saharan Africa report having received cervical can-
cer screening [12–19]. This is even lower in the East
African region where the prevalence of human papil-
loma virus (HPV) (20%) is high, and the incidence rates
of cervical cancer are highest [20]. Understanding factors
that influence intention to screen for cervical cancer
among women is important to inform programmes
aimed at increasing utilisation of screening services in
sub-Saharan Africa. Previous studies show that women’s
intention to screen, and attendance of cervical cancer
screening is influenced by: demographic factors such as
occupation, living with a partner; attitudinal factors such
as perception of risk and disease; social factors for ex-
ample discussions by health workers; and health system
factors such as distance to health facilities and awareness
of the service [18, 19].
HPV, which is mainly sexually transmitted, causes
most of the cervical cancer cases [21]. Highly effective
prophylactic vaccines against HPV −16 and HPV −18
have been shown to prevent over 70% of these cases
worldwide [22]. HPV vaccinations can therefore signifi-
cantly reduce the incidence of cervical cancer among
women. Moreover, WHO recommends offering HPV
vaccine to girls between 9 and 13 years, prior to sexual
debut, as the vaccine is most efficacious if girls have not
already been exposed to the virus [23]. The success of
the vaccine would depend on levels of acceptability and
uptake, which heavily relies on parent’s willingness to
have their eligible daughters vaccinated [24]. Prior re-
search among parents has reported predictors of vacci-
nations of girls to include perception of the severity of
the disease, belief of daughter being at risk, higher edu-
cation and income, attitudes towards vaccines, previous
awareness of the vaccine, and recommendations by vac-
cine providers [7, 25–28]. Barriers to cervical cancer
vaccination such as concerns about vaccine safety, dan-
ger to daughter, sexual behaviours, and lack of provider
recommendation have also been highlighted [7, 25–29].
However, there has been a paucity of such studies in
Uganda to provide context specific barriers and inform
on-going vaccine promotion campaigns. This study
assessed the factors associated with intention to screen
for cervical cancer among women in eastern Uganda,




The study was conducted in Bugiri and Mayuge districts
in eastern Uganda approximately 150 kilometres from
Kampala, the country’s capital city. These predominantly
rural districts have a combined area of 10,372 km2 and a
total population of 856,152 people of whom 51.4% are
females [30]. Bugiri district is composed of 9 sub-
counties while Mayuge has 7 sub-counties. Majority of
people in the districts reside in roofed mud and wattle
houses. Residents majorly participate in agriculture for
subsistence though a few operate small businesses in
trading centres, and others engage in fishing along the
shores of Lake Victoria. In the two districts, cervical can-
cer screening is provided by Bugiri district hospital, a
government health facility that also serves neighbouring
districts. The hospital provides intermittent screening
services and treatment of those diagnosed with the dis-
ease. Three (3) private health facilities, 2 in Bugiri and 1
in Mayuge district, also provide cervical cancer screening.
Study design and population
This was a cross sectional study that employed quantita-
tive data collection methods. The study involved females
aged 25 to 49 years in Bugiri and Mayuge districts who
had lived in the area for at least six months. A minimum
sample size of 845 was determined using the sample size
estimation formula for cross sectional studies [31] with
Z = 1.96, p = 0.5 (used to obtain the maximum sample
size since proportion was not known), and a precision of
5% taking into account a design effect of 2.0, and a non-
response rate of 10%. The sampling units were house-
holds, and only one participant was interviewed per
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selected household with priority given to household
heads or their spouses.
Sampling
Multi-stage sampling technique was used as follows: five
sub-counties were randomly selected from each district.
Five villages were then selected from each sub-county
using simple random sampling to obtain 25 study vil-
lages in each district. Lists of sub-counties and villages
were obtained from district officials while village Local
Council leaders provided estimates of numbers of house-
holds in their villages. The study households were
selected using systematic random sampling where the
interval for selection was determined by dividing the ap-
proximate number of households in a given village by
the required number of respondents.
Data collection
Data were collected using a pretested semi-structured
questionnaire that was developed in English, and then
translated to Lusoga, the main local language of the area.
The questionnaire had questions on knowledge and atti-
tudes towards cervical cancer and screening, access to
cervical cancer screening and intention to screen, re-
spondent willingness to vaccinate their daughters, and
socio-demographic factors whose details have been de-
scribed elsewhere [19]. The questionnaire was adminis-
tered by a team of trained Research Assistants at
respondents’ homes.
Data analysis
Data were entered in Epidata version 3.02 (EpiData
Association, Denmark) and analysed in STATA version
12.0 (Stata Corp, Texas, USA) statistical software. The
outcome variables were intention to screen for cervical
cancer in the following six months, and willingness for
vaccination of daughters against cervical cancer.
Intention to screen was assessed using a question which
asked respondents “Do you intend to go for cervical can-
cer screening in the next six months?” with three re-
sponses of ‘Yes’ ‘No’ and “Undecided”. ‘Yes’ and ‘No’
responses formed the binary outcome variable and were
assigned 1 and 0 respectively during further analysis. For
willingness to vaccinate daughters against cervical can-
cer, respondents answered to the statement “I would
allow my children to be vaccinated against cervical can-
cer” with response based on a 5 point - Likert scale
ranging from strongly disagree to strongly agree.
Respondents who gave ‘Strongly agree’ and ‘Agree’ re-
sponses were coded as ‘willing to allow their daughters
receive vaccination’ and assigned 1 while those who
responded with ‘Strongly disagree’ and ‘Disagree’ re-
sponses were coded as not willing to allow their daugh-
ters to be vaccinated’ (assigned 0). Those who were not
sure were dropped in creating this outcome variable.
Prevalence ratios (PR) computed using a generalized lin-
ear model with Poisson family, and a log link with
robust standard errors while applying a backward elim-
ination method were used to measure the association
between the outcome and independent variables. PRs
were used because the outcomes were highly prevalent
(>10%) as odds ratios tend to overestimate the relative
risk in such instances [32–34]. Simple models were run
to obtain the unadjusted PRs, and then basing on bio-
logical plausibility and p < 0.05, variables from these
models were included in the multivariable model. We
present both the unadjusted and adjusted PRs, and their
corresponding 95% confidence intervals (CI) as well as
p-values. A p-value of less than 0.05 was considered for
a statistically significant association.
Results
Socio-demographic characteristics of respondents
All the 900 respondents selected took part in the study.
Majority of these were from rural areas 610 (67.8%) and
married 767 (85.2%). Only a quarter 228 (25.3%) of re-
spondents had attained post primary education (Table 1).
Intention to screen for cervical cancer
Majority 819 (91.0%) of respondents stated that they
intended to go for cervical cancer screening in the fol-
lowing six months. Only 57 (6.3%) did not intend to
undergo the procedure while 24 (2.7%) were undecided.
Reasons for intention to screen were: 603 (73.6%) to
know status, 256 (31.3%) thought it was important, 202
(24.7%) wanted to reduce their chances of getting the
disease, and 20 (2.4%) had been told to do so by a health
worker. Among those who did not intend to screen, 28
(49.1%) stated that it was not necessary or important, 9
(15.8%) cited health facility being far away, 6 (10.5%)
high costs involved, 5 (8.8%) said they had been screened
recently, and 13 (22.8%) gave other reasons (fear of pain,
lack of signs and symptoms, and already undergoing
treatment). Among respondents who had never screened
for cervical cancer, intention to screen was at 91.6%
(785/857). When respondents were asked whether they
would be willing to undergo screening if the service
was offered at an affordable cost to them, majority
828 (92.0%) said they would. Moreover, 863 (95.9%)
stated willingness to screen if the service was pro-
vided free of charge.
Respondents’ willingness for vaccination of themselves
and their daughters
Of the study respondents, more than nine in ten 815
(90.5%) reported willingness to be vaccinated against
cervical cancer if it were recommended. The rest re-
ported unwillingness 61 (6.8%) or uncertainty 24 (2.7%).
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Majority 813 (90.4%) also reported that they would allow
their daughters to be vaccinated against cervical cancer,
59 (6.6%) wouldn’t and the rest 28 (3.1%) were
undecided.
Socio-demographic characteristics associated with
intention to screen, and willingness to vaccinate
daughters against cervical cancer
Respondents from Mayuge district (unadjusted PR = 1.10,
95% CI = 1.06–1.14) and those whose households earned
40 US dollars or more per month (unadjusted PR = 1.07,
95% CI = 1.04–1.11) had a 10% and 7% higher intention to
screen for cervical cancer respectively compared with their
counterparts. On the other hand, respondents who had
accessed cervical cancer screening were less likely to intend
to undergo another test in the subsequent six months
(unadjusted PR = 0.86, 95% CI = 0.74–0.99). The re-
spondents’ district of residence (unadjusted PR = 1.05,
95% CI = 1.01–1.09), residence in a rural or urban
area (unadjusted PR = 1.05, 95% CI = 1.01–1.08), occu-
pation (unadjusted PR = 0.94, 95% CI = 0.91–0.98), and
household income (unadjusted PR = 1.05, 95% CI = 1.01–
1.08) were all significantly associated with willingness to
vaccinate their daughters against cervical cancer (Table 2).
Knowledge factors associated with intention to screen,
and willingness to vaccinate daughters against cervical
cancer
Reporting that early detection of cervical cancer is help-
ful (unadjusted PR = 1.18, 95% CI = 1.02–1.36), knowing
that one could be vaccinated against cervical cancer
(unadjusted PR = 1.05, 95% CI = 1.01–1.09), and know-
ledge of at least one test for cervical cancer (unadjusted
PR = 0.95, 95% CI = 0.91–0.98) were significantly associ-
ated with intention to screen for cervical cancer at bi-
variate analysis. On the other hand, knowing that one
could be vaccinated against cervical cancer (unadjusted
PR = 1.05, 95% CI = 1.01–1.10), knowing more than one
preventive measure (unadjusted PR = 0.96, 95% CI = 0.91–
0.99) or symptom of cervical cancer (unadjusted PR =
0.94, 95% CI = 0.01–0.97), and knowledge of at least one
test for cervical cancer (unadjusted PR = 0.96, 95% CI =
0.93–0.99) were significantly associated with willingness
to vaccinate daughters against cervical cancer (Table 3).
Attitude factors associated with intention to screen and
willingness to vaccinate daughters against cervical cancer
Majority 796 (96.1%) of respondents thought that cer-
vical cancer was a severe disease and these had a signifi-
cantly higher intention to screen (unadjusted PR = 2.12,
95% CI = 1.52–2.96). Other attitudinal factors associated
with intention to screen for cervical cancer were: belief
of being at risk of getting cervical cancer (unadjusted
PR = 1.29, 95% CI = 1.14–1.48), stating that cervical can-
cer screening is important (unadjusted PR = 1.81, 95%
CI = 1.34–2.45), and that chances of curing cervical can-
cer are better when it is discovered at an early stage (un-
adjusted PR = 1.22, 95% CI = 1.11–1.34), and that their
family would approve of children being vaccinated
against cervical cancer (unadjusted PR = 1.70, 95% CI =
1.36–2.13). Similarly, respondents who stated that cer-
vical cancer is a severe disease (unadjusted PR = 5.68,
95% CI = 2.89–11.12), believed were at risk of getting
cervical cancer (unadjusted PR = 1.72,, 95% CI = 1.42–
2.07), stated that; cervical cancer screening is important
(unadjusted PR = 5.28, 95% CI = 2.70–10.32), the chances
of curing cervical cancer are better when the disease is
discovered at an early stage (unadjusted PR = 1.38, 95%
CI = 1.23–1.55), and that their family would approve of
Table 1 Socio-demographic characteristics of respondents
(N = 900)
Characteristic Categories n (%)
District Bugiri 452 (50.2)
Mayuge 448 (49.8)
Residence Rural 610 (67.8)
Semi-urban/urban 290 (32.2)
Age (years) Mean (SD) 32.9 (±6.7)
25–39 703 (78.1)
40–49 197 (21.9)
Education level None/primary 672 (74.7)
Post primary 228 (25.3)
Religion Muslims 382 (42.4)
Christians 518 (57.6)
Marital status Single 133 (14.8)
Married 767 (85.2)




Parity Mean (SD) 5.04 (±2.7)
Four and below 430 (47.8)
Above four 470 (52.2)
Household monthly income Less than $40 622 (69.1)
$40 and above 278 (30.9)
Household head No 757 (84.1)
Yes 143 (15.9)
Ever tested for HIV No 144 (16.0)
Yes 756 (84.0)




Cervical cancer screening status Not screened 857 (95.2)
Screened 43 (4.8)
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children being vaccinated against cervical cancer (un-
adjusted PR = 6.38, 95% CI = 3.49–11.63) had a signifi-
cantly higher willingness to vaccinate their daughters
against the disease (Table 4).
Health facility factors associated with intention to screen
and willingness to vaccinate against cervical cancer
Respondents who accessed health care (unadjusted PR =
0.95, 95% CI = 0.92-0.99) and reproductive health care
(unadjusted PR = 0.96, 95% CI = 0.92–0.99) from a gov-
ernment health facility, and those who knew where cer-
vical cancer screening was provided (unadjusted PR =
0.94, 95% CI = 0.91–0.98) had a lower intention to screen
for cervical cancer compared with their counterparts. On
the other hand, respondents who lived within 5 kilometres
from the health facility where screening services were pro-
vided had a higher intention to screen for cervical cancer
(unadjusted PR = 1.12, 95% CI = 1.04–1.20). Similarly, re-
spondents who lived within 5 kilometres from the health
facility had a higher willingness for vaccination of their
daughters (unadjusted PR = 1.13, 95% CI = 1.05–1.21). In
contrast, there was less willingness for respondents
who accessed health care (unadjusted PR = 0.96 95%
CI = 0.92–0.99) and reproductive health care (un-
adjusted PR = 0.95, 95% CI = 0.91-0.98) from a govern-
ment health facility, those who found it easy to
access reproductive health care (unadjusted PR = 0.97,
95% CI = 0.93–1.00), and those who knew where
Table 2 Knowledge factors with intention to screen and willingness to vaccinate daughters against cervical cancer
Intention to screen (n = 819) Willingness to vaccinate daughters (n = 813)
Characteristic N (%) Unadjusted PR (95% CI) p-value N (%) Unadjusted PR (95% CI) p-value
Early detection of cervical cancer is helpful
No 36 (80.0) 39 (86.7)
Yes 783 (94.2) 1.18 [1.02–1.36] 0.029* 774 (93.6) 1.08 [0.96–1.21] 0.194
Cervical cancer can be prevented
No 246 (92.8) 246 (92.1)
Yes 573 (93.8) 1.01 [0.97–1.05] 0.611 567 (93.7) 1.02 [0.98–1.06] 0.412
Knew recommended age for start of cervical cancer screening
No 785 (93.6) 782 (93.5)
Yes 34 (91.9) 0.98 [0.89–1.08] 0.717 31 (86.1) 0.92 [0.81–1.05] 0.221
Knew that one can be vaccinated against cervical cancer
No 282 (90.7) 280 (90.0)
Yes 537 (95.0) 1.05 [1.01–1.09] 0.022* 533 (95.0) 1.05 [1.01–1.10] 0.011*
Knew more than one preventive measure for cervical cancer
No 570 (93.4) 580 (94.5)
Yes 249 (93.6) 1.00 [0.96–1.04] 0.927 233 (90.3) 0.96 [0.91–0.99] 0.047*
Knew more than one symptom of cervical cancer
No 382 (95.0) 387 (96.3)
Yes 437 (92.2) 0.97 [0.94–1.00] 0.085 426 (90.6) 0.94 [0.01–0.97] 0.001*
Knew at least one test for cervical cancer
No 455 (95.8) 448 (94.9)
Yes 364 (90.8) 0.95 [0.91–0.98] 0.004* 365 (91.2) 0.96 [0.93–0.99] 0.036*
Knew someone who had ever been screened for cervical cancer
No 538 (93.6) 546 (94.5)
Yes 281 (93.4) 0.99 [0.96–1.03] 0.905 267 (90.8) 0.96 [0.92–1.00] 0.062
Knew someone who had ever been diagnosed with cervical cancer
No 569 (93.3) 576 (93.9)
Yes 250 (93.9) 1.00 [0.97–1.04] 0.691 237 (91.5) 0.97 [0.93–1.01] 0.218
Knew someone who had died from cervical cancer
No 568 (93.3) 572 (93.6)
Yes 251 (94.0) 1.00 [0.97–1.04] 0.676 241 (92.3) 0.99 [0.95–1.03] 0.507
*p < 0.05
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cervical cancer screening was provided (unadjusted
PR = 0.93, 95% CI = 0.89–0.97) (Table 5).
Predictors of intention to screen and willingness to vaccinate
daughters against cervical cancer
When all factors were examined simultaneously in rela-
tion to intention to screen, respondents whose households
earned 40 US dollars and above per month had a signifi-
cantly higher intention to screen for cervical cancer com-
pared to those who earned less than 40 dollars (adjusted
PR = 1.11, 95% CI: 1.03–1.20). Cervical cancer screening
status (adjusted PR = 0.81, 95% CI: 0.67–0.99) and know-
ledge of at least one test for cervical cancer was sig-
nificantly associated with intention to screen (adjusted
Table 3 Attitudes with intention to screen and willingness to vaccinate daughters against cervical cancer
Intention to screen (n = 819) Willingness to vaccinate daughters (n = 813)
N (%) Unadjusted PR (95% CI) p-value N (%) Unadjusted PR (95% CI) p-value
Cervical cancer is a severe disease
No 19 (45.2) 7 (17.1)
Yes 796 (96.1) 2.12 [1.52–2.96] <0.001* 800 (96.9) 5.68 [2.89–11.12] <0.001*
I am at risk of getting cervical cancer
No 62 (73.8) 47 (56.6)
Yes 642 (95.8) 1.29 [1.14–1.48] <0.001* 647 (97.3) 1.72 [1.42–2.07] <0.001*
Cervical cancer screening is important
No 20 (52.6) 7 (18.4)
Yes 788 (95.4) 1.81 [1.34–2.45] <0.001* 802 (97.3) 5.28 [2.70–10.32] <0.001*
Only women who are sexually active need cervical cancer screening
Yes 373 (95.9) 378 (96.9)
No 358 (90.9) 0.95 [0.91–0.98] 0.005 351 (89.5) 0.92 [0.89–0.96] <0.001*
Women who have had sexually transmitted infections are more likely to get cervical cancer
No 169 (86.2) 152 (79.2)
Yes 578 (96.0) 1.11 [1.05–1.18] <0.001* 588 (97.7) 1.23 [1.15–1.33] <0.001*
Chances of curing cervical cancer are better when the disease is discovered at an early stage
No 97 (78.9) 89 (70.6)
Yes 666 (96.2) 1.22 [1.11–1.34] <0.001* 671 (97.7) 1.38 [1.23–1.55] <0.001*
Cervical cancer is not a death sentence for most people
No 320 (95.0) 319 (94.9)
Yes 407 (92.5) 0.97 [0.94–1.01] 0.157 401 (91.3) 0.96 [0.93–0.99] 0.046*
There is much a woman can do to reduce her chances of getting cervical cancer
No 415 (95.6) 410 (95.1)
Yes 272 (90.7) 0.95 [0.91–0.99] 0.012* 269 (89.1) 0.94 [0.89–0.98] 0.004*
Women who have cervical cancer will have some symptoms showing it
Yes 700 (96.1) 706 (97.4)
No 53 (68.8) 0.71 [0.61–0.83] <0.001* 41 (54.7) 0.56 [0.46–0.69] <0.001*
Cervical cancer runs in families
No 371 (92.7) 361 (91.2)
Yes 302 (94.4) 1.02 [0.98–1.05] 0.374 307 (95.0) 1.04 [1.00–1.08] 0.039*
Women only need cervical cancer screening tests during child bearing years
Yes 412 (95.8) 412 (96.5)
No 321 (89.7) 0.93 [0.89–0.97] 0.001* 318 (89.1) 0.92 [0.89–0.96] <0.001*
Their family would approve of children being vaccinated against cervical cancer
No 34 (56.7) 9 (15.5)
Yes 752 (96.5) 1.70 [1.36–2.13] <0.001* 778 (98.9) 6.38 [3.49–11.63] <0.001*
*p < 0.05
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PR = 0.92, 95% CI: 0.85–0.98). Among attitude factors,
although not statistically significant, respondents who
stated that cervical cancer was a severe disease had
an 81% higher intention to screen (adjusted PR = 1.81
95% CI: 0.96–3.42) while the prevalence of intention
to screen was 37% higher among respondents whose
families would approve of children being vaccinated
against cervical cancer (adjusted PR = 1.37, 95% CI:
0.83–2.26) compared with their counterparts.
No sociodemographic characteristic was associated
with willingness to vaccinate daughters against cervical
cancer. Additionally, respondents who knew more than
one symptom of cervical cancer had a lower prevalence
of willingness to vaccinate daughters against cervical
cancer (adjusted PR = 0.89, 95% CI: 0.81–0.98). Although
not statistically significant, the prevalence of willingness
to vaccinate daughters was over 4 times higher among
respondents who stated that cervical cancer screening
was important (adjusted PR = 4.36, 95% CI: 0.38–49.2)
and over 3 times higher among those whose families
would approve of children being vaccinated against
cervical cancer (adjusted PR = 3.87, 95% CI: 0.79–19.04)
compared with their counterparts. No attitude and
health facility factors were associated with willingness to
vaccinate daughters against cervical cancer (Table 6).
Discussion
This study assessed the socio-demographic, knowledge,
attitudinal and health facility factors associated with
women’s intention to screen, and willingness to vaccin-
ate their daughters against cervical cancer in eastern
Uganda. Overall, 91% of respondents reported intention
to screen for cervical cancer in the subsequent six
months. This intention to screen increased to 92% if the
service would be offered at an affordable cost, and to
95.9% if provided free of charge. This intention to screen
for cervical cancer is higher than the 63% reported by a
previous study conducted in southern Ugandan [18].
Although intention to screen was this high and respon-
dents relatively knowledgeable about cervical cancer and
screening [35], actual uptake of cervical cancer screening
in this population of women was very low at 4.8% as
Table 4 Health facility factors with intention to screen and willingness to vaccinate daughters against cervical cancer
Intention to screen (n = 819) Willingness to vaccinate daughters (n = 813)
Characteristic N (%) Unadjusted PR (95% CI) p-value N (%) Unadjusted PR (95% CI) p-value
Where health care is accessed when sick
Private facility 166 (97.1) 168 (96.5)
Government facility 653 (92.6) 0.95 [0.92–0.99] 0.006* 645 (92.4) 0.96 [0.92–0.99] 0.015*
Where reproductive health care is accessed
Private facility 153 (96.8) 157 (97.5)
Government facility 666 (92.8) 0.96 [0.92–0.99] 0.016* 656 (92.3) 0.95 [0.91–0.98] 0.001*
Ease of access of reproductive health care
Very/somewhat difficult 372 (92.8) 378 (94.9)
Not difficult 447 (94.1) 1.01 [0.98–1.05] 0.428 435 (91.8) 0.97 [0.93–1.00] 0.056
Have challenges in accessing reproductive health care
Yes 480 (92.5) 487 (94.0)
No 339 (95.0) 1.02 [0.99–1.06] 0.131 326 (92.1) 0.98 [0.94–1.02] 0.279
Ever been recommended for screening by health worker
No 749 (94.0) 737 (92.9)
Yes 70 (88.6) 0.94 [0.87–1.02] 0.155 76 (96.2) 1.03 [0.99–1.08] 0.157
Knew where cervical cancer screening is provided
No 496 (95.7) 489 (95.9)
Yes 323 (90.2) 0.94 [0.91–0.98] 0.003* 324 (89.5) 0.93 [0.89–0.97] 0.001*
Distance to health facility where screening is done (n–372)
5 or more km 140 (84.8) 139 (84.2)
Less than 5 km 183 (94.8) 1.12 [1.04–1.20] 0.003* 187 (94.9) 1.13 [1.05–1.21] 0.001*
Distance to nearest health facility
5 or more km 128 (91.4) 125 (89.9)
Less than 5 km 691 (93.9) 1.03 [0.97–1.08] 0.336 688 (93.9) 1.04 [0.98–1.10] 0.153
*p < 0.05
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Table 5 Socio-demographic characteristics with intention to screen, and willingness to vaccinate daughters against cervical cancer
Characteristic Intention to screen (n = 819) Willingness to vaccinate daughters (n = 813)
N (%) Unadjusted PR (95% CI) p-value N (%) Unadjusted PR (95% CI) p-value
District
Bugiri 388 (89.0) 404 (90.9)
Mayuge 431 (97.9) 1.10 [1.06–1.14] <0.001* 409 (95.6) 1.05 [1.01–1.09] 0.007*
Residence
Rural 551 (92.6) 542 (91.9)
Semi-urban/urban 268 (95.4) 1.03 [0.99–1.06] 0.093 271 (96.1) 1.05 [1.01–1.08] 0.009*
Age (years)
25–39 643 (93.7) 638 (93.5)
40–49 176 (92.6) 0.99 [0.94–1.03] 0.603 175 (92.1) 0.98 [0.94–1.03] 0.508
Education level
None/primary 617 (94.0) 610 (93.7)
Post primary 202 (91.8) 0.98 [0.93–1.02] 0.283 203 (91.9) 0.98 [0.94–1.02] 0.376
Religion
Muslims 353 (94.9) 350 (94.6)
Christians 466 (92.5) 0.97 [0.94–1.00] 0.138 463 (92.2) 0.97 [0.94–1.01] 0.159
Marital status
Single 118 (92.9) 120 (93.7)
Married 701 (93.6) 1.01 [0.96–1.06] 0.782 693 (93.1) 0.99 [0.95–1.04] 0.795
Occupation
Farming 458 (94.2) 470 (95.5)
Other (business, housewife,
civil servant)
361 (92.6) 0.98 [0.95–1.02] 0.325 343 (90.3) 0.94 [0.91–0.98] 0.004*
Parity
Above four 426 (92.4) 429 (93.5)
Four and below 393 (94.7) 1.02 [0.99–1.06] 0.167 384 (92.9) 0.99 [0.96–1.03] 0.776
Household monthly income
Less than $40 551 (91.4) 552 (91.8)
$40 and above 268 (98.2) 1.07 [1.04–1.11] <0.001* 261 (96.3) 1.05 [1.01–1.08] 0.005
Household head
No 688 (93.3) 688 (93.3)
Yes 131 (94.2) 1.01 [0.96–1.06] 0.681 125 (92.6) 0.99 [0.94–1.04] 0.756
Ever tested for HIV
No 133 (94.3) 133 (95.0)
Yes 686 (93.3) 0.99 [0.95–1.03] 0.644 680 (92.9) 0.98 [0.94–1.02] 0.307
Ever used modern family planning method
No 283 (92.5) 279 (91.8)
Yes 536 (94.0) 1.02 [0.98–1.06] 0.392 534 (94.0) 1.02 [0.98–1.06] 0.233
Cervical cancer screening status
Not screened 785 (94.1) 774 (93.2)
Screened 34 (80.9) 0.86 [0.74–0.99] 0.046* 39 (92.9) 0.99 [0.91–1.08] 0.923
*p < 0.05
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Table 6 Independent predictors of intention to screen and willingness to vaccinate daughters against cervical cancer
Intention to screen Willingness to vaccinate
Characteristic Adjusted PR (95% CI) p-value Adjusted PR (95% CI) p-value
District (Bugiri)
Mayuge 1.06 [0.99–1.13] 0.072 1.05 [0.97–1.13] 0.248
Residence (Rural)
Semi-urban/urban 1.05 [0.98–1.14] 0.155 - -
Age in years (25–39)
40–49 1.01 [0.92–1.12] 0.845 1.04 [0.99–1.10] 0.133
Education level (None/primary)
Post primary 0.93 [0.84–1.03] 0.170 0.97 [0.92–1.02] 0.231
Religion (Muslims)
Christians 0.92 [0.85–1.00] 0.059 0.97 [0.93–1.01] 0.172
Household monthly income (Less than $40)
$40 and above 1.11 [1.03–1.20] 0.004* 1.03 [0.99–1.07] 0.149
Cervical cancer screening status (No)
Yes 0.81 [0.67–0.99] 0.037* 1.01 [0.93–1.11] 0.769
Knowledge factors
Early detection of cervical cancer is helpful (No)
Yes 1.07 [0.92–1.24] 0.407 - -
Knew that one can be vaccinated against cervical cancer (No)
Yes 1.00 [0.92–1.08] 0.998 0.99 [0.96–1.04] 0.959
Knew more than 1 preventive measure for cervical cancer (No)
Yes - - 1.04 [0.99–1.09] 0.136
Knew more than 1 symptom of cervical cancer (No)
Yes 0.93 [0.86–1.01] 0.078 0.89 [0.81–0.98] 0.020*
Knew at least one test for cervical cancer (No)
Yes 0.92 [0.85–0.98] 0.017* 0.99 [0.93–1.05] 0.655
Attitude factors
Cervical cancer is a severe disease (No)
Yes 1.81 [0.96–3.42] 0.068 1.36 [0.79–2.30] 0.258
I am at risk of getting cervical cancer (No)
Yes 0.89 [0.78–1.03] 0.127 1.04 [0.86–1.27] 0.660
Cervical cancer screening is important (No)
Yes 0.61 [0.34–1.09] 0.097 4.36 [0.38–49.2] 0.234
Only women who are sexually active need cervical cancer screening (Yes)
No - - 1.02 [0.97–1.06] 0.479
Women who have had sexually transmitted diseases are more likely to get cervical cancer (No)
Yes 1.05 [0.97–1.14] 0.190 1.03 [0.97–1.09] 0.303
Chances of curing cervical cancer are better when the disease is discovered at an early stage (No)
Yes 0.99 [0.92–1.08] 0.947 0.97 [0.91–1.03] 0.338
Cervical cancer is not a death sentence for most people (No)
Yes - - 0.99 [0.95–1.04] 0.790
There is much a woman can do to reduce her chances of getting cervical cancer (No)
Yes 1.02 [0.95–1.08] 0.697 1.00 [0.97–1.03] 0.929
Women who have cervical cancer will have some symptoms showing it (Yes)
Ndejjo et al. BMC Public Health  (2017) 17:255 Page 9 of 12
reported in a related study [19]. This therefore calls for
an in-depth exploration of the barriers that could be
limiting most of these women from accessing cervical
cancer screening. In fact, respondents who did not in-
tend to screen majorly stated that screening was neither
necessary nor important highlighting the presence of
knowledge gaps that should be filled through adequate
sensitisation of women to appreciate the severity of the
disease and increase their risk perception. Therefore, in-
creasing access to cervical cancer screening services and
further education of women is expected to increase up-
take rates of screening services which are currently low
in developing countries including Uganda.
The target group for HPV vaccinations being pre-
pubescent girls, parental approval is required for the
success of vaccination programmes [24]. In this study,
we found a high willingness of 90.4% among women to
vaccinate their daughters against cervical cancer. This is
in line with proportions of over 90% reported by Kenyan
[36, 37] and Ghanaian [7] studies. However, these stud-
ies majorly targeted urban women at health centres un-
like our study that had majority rural participants in the
community. This high willingness in our study could
have been contributed to by the high acceptability and
uptake of vaccines in Uganda [5], a determinant of HPV
vaccine acceptability among parents [7, 25, 28]. There
are also ongoing campaigns by the government of
Uganda aimed at HPV vaccinations of girls aged between
9 to 13 years which could have increased awareness of
cervical cancer and vaccinations. As there is high
willingness to vaccinate daughters, the focus of various
stakeholders such as the Ministry of Health and
Non-governmental Organisations should be turning this
into actual practice through increasing service availabil-
ity and accessibility by using effective strategies such as
schools, health centres, and community based pro-
grammes [5, 8].
In the study, there was a significant association be-
tween having higher income and intention to screen
against cervical cancer. Moreover, intention to screen in-
creased with possibilities of affordable and free cervical
cancer screening which could highlight the cost of the
procedure as a barrier as reported elsewhere [16, 19, 38].
Prior studies have also found associations between
higher income and uptake of cervical cancer screening
[17, 39, 40]. This highlights the need to ensure the
provision of affordable or free cervical cancer screening
services to increase uptake of the service among women
in developing countries. We also found that respondents
who had already accessed screening, and those who
knew at least one test for cervical cancer were less likely
to intend to screen in the subsequent six months. It is
likely that respondents who knew the screening tests
had been screened for cervical cancer as earlier
highlighted [19]. Since these respondents had already
been screened, though at various intervals [19], they
could have been reluctant to access screening in the fol-
lowing six months. Indeed, the WHO recommends
screening for cervical cancer at 3 year intervals among
women aged 30 years and above [11]. Similarly, the
Ugandan Ministry of Health strategic plan for cervical
cancer prevention and control 2010–2014 recommends
screening for cervical cancer once every three years for
HIV negative women, and annually for those who are
Table 6 Independent predictors of intention to screen and willingness to vaccinate daughters against cervical cancer (Continued)
No 0.86 [0.71–1.06] 0.157 0.86 [0.72–1.02] 0.085
Cervical cancer runs in families (No)
Yes - - 0.98 [0.95–1.02] 0.410
Women only need cervical cancer screening tests during child bearing years (No)
No 0.99 [0.92–1.06] 0.802 0.97 [0.93–1.02] 0.228
Their family would approve of children being vaccinated against cervical cancer (No)
Yes 1.37 [0.83–2.26] 0.217 3.87 [0.79–19.04] 0.096
Health facility factors
Where health care is accessed (Private facility)
Government facility 0.93 [0.82–1.05] 0.240 1.03 [0.87–1.20] 0.749
Where reproductive health care is accessed (Private facility)
Government facility 1.11 [0.89–1.39] 0.351 0.95 [0.86–1.05] 0.347
Knew where cervical cancer screening is provided (No)
Yes 1.13 [0.97–1.32] 0.121 1.08 [0.96–1.23] 0.189
Distance to health facility where screening is done (5 or more km)
Less than 5 km 1.07 [0.98–1.17] 0.124 1.03 [0.98–1.08] 0.271
*p < 0.05
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HIV positive [6]. Nonetheless, a study in Kenya [17]
found lower intentions to screen among women who
had already been screened while a Chinese study re-
ported otherwise [41]. Respondents who knew more
than one symptom of the disease had lower willingness
to vaccinate their daughters. It is possible that such re-
spondents were reluctant to take up interventions in
cases where they knew how the disease could manifest
yet they had not observed these. Indeed, it has been re-
ported that women may for example not access cervical
cancer screening because they do not have any signs and
symptoms of the disease [18, 19]. Sensitization cam-
paigns should emphasize the asymptomatic nature of
cervical cancer especially during its early stages and en-
courage women to access cervical cancer services even
when they do not have any signs or symptoms of the
disease. Among the attitudinal factors, although not sta-
tistically significant, respondents whose families would
approve of daughters being vaccinated against cervical
cancer were more likely to intend to screen for the dis-
ease, and more willing to have their daughters vacci-
nated against it. Study respondents being women, this
could indicate a gender influence which has been shown
to affect health care decision making in many African
households [42, 43]. For example, previous studies have
shown that sometimes women may require approval and
financial support from their husbands to seek cervical
cancer screening [18, 42, 43] emphasizing the import-
ance of social influence from important others such as
spouses. On the other hand, this finding could indicate
the desire for collective decision making among parents
especially when it comes to the vaccination of their
daughters as reported by another study [7]. Overall, this
underscores the need for involvement of all societal
groups especially men in programmes aimed at increas-
ing cervical cancer screening and vaccination.
This study examined intention to screen, and willing-
ness to vaccinate daughters among a majorly rural popu-
lation, and had a large sample size compared with other
sub-Saharan Africa studies. However, some elements of
this study for example intention to screen, and willing-
ness to vaccinate daughters could have been affected by
the tendency for study participants to give socially desir-
able responses which could have introduced bias. We
also did not assess knowledge about HPV and the vac-
cine whose relationship with vaccination acceptability
would have been relevant to explore, and neither did we
assess reasons for willingness to vaccinate daughters
among the sampled women. Nevertheless, this study
contributes important information regarding intention
to screen among women and willingness to vaccinate
daughters against cervical cancer and associated factors
which can inform future studies as well as cervical can-
cer programmes.
Conclusion
There was a very high intention to screen and willing-
ness to vaccinate daughters against cervical cancer
among women in eastern Uganda. Only higher income
predicted intention to screen for cervical cancer while
respondents whose families would approve of their
daughters being vaccinated against cervical cancer were
more likely to intend to screen for the disease and will-
ing for their daughters to be vaccinated. To take advan-
tage of the high rates of intention to screen, and
willingness to vaccinate daughters against cervical can-
cer, opportunities should be availed for women to access
screening, and for girls to be vaccinated against the dis-
ease. In addition, the involvement of all societal groups
especially men in programmes aimed at increasing
screening and vaccinations of girls could increase uptake
of these services.
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